Head and neck mucosal melanoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 6, 2005, Pages 626-630

  Mendenhall, William M ^a,b   Amdur, Robert J ^a   Hinerman, Russell W ^a   Werning, John W ^a   Villaret, Douglas B ^a   Mendenhall, Nancy Price ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Mucosal melanoma; Outcomes; Radiotherapy; Treatment

Indexed keywords

CANCER VACCINE; INTERFERON;

CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INOPERABLE CANCER; MELANOMA; METASTASIS; MOUTH CANCER; NOSE CAVITY CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PARANASAL SINUS CANCER; POSTOPERATIVE CARE; PROGNOSIS; REVIEW; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOTHERAPY; INCIDENCE; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; MUCOUS MEMBRANE; NASAL MUCOSA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NOSE NEOPLASMS; PALATAL NEOPLASMS; PARANASAL SINUS NEOPLASMS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 29044436040     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000170805.14058.d3     Document Type: Review

References (25)

1. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664-1678.
2. Andersen LJ, Berthelsen A, Hansen HS. Malignant melanoma of the upper respiratory tract and the oral cavity. J Otolaryngol. 1992;21:180-185.
3. Conley J, Pack GT. Melanoma of the mucous membranes of the head and neck. Arch Otolaryngol. 1974;99:315-319.
4. Brandwein MS, Rothstein A, Lawson W, et al. Sinonasal melanoma. A clinicopathologic study of 25 cases and literature meta-analysis. Arch Otolaryngol Head Neck Surg. 1997;123:290-296.
5. Batsakis JG, Regezi JA, Soloman AR, et al. The pathology of head and neck tumors: mucosal melanomas, part 13. Head Neck Surg. 1982;4:404-418.
6. Lee SP, Shimizu KT, Tran LM, et al. Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope. 1994;104:121-126.
7. Loree TR, Mullins AP, Spellman J, et al. Head and neck mucosal melanoma: a 32-year review. Ear Nose Throat J. 1999;78:372-375.
8. Temam S, Mamelle G, Marandas P, et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer. 2004;103:313-319.
9. Prasad ML, Patel SG, Busam KJ. Primary mucosal desmoplastic melanoma of the head and neck. Head Neck. 2004;26:373-377.
10. Kilpatrick SE, White WL, Browne JD. Desmoplastic malignant melanoma of the oral mucosa. An unrecognized diagnostic pitfall. Cancer. 1996;78:383-389.
11. Prasad ML, Patel SG, Huvos AG, et al. Primary mucosal melanoma of the head and neck. A proposal for microstaging localized, stage I (lymph node-negative) tumors. Cancer. 2004;100:1657-1664.
12. Goerres GW, Stoeckli SJ, Schulthess GK, et al. FDG PET for mucosal malignant melanoma of the head and neck. Laryngoscope. 2002;112:381-385.
13. Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer. 1997;80:1373-1386.
14. American Joint Committee on Cancer. Head and neck sites. 6th ed. Springer, New York; 2002:17-87.
15. Stern SJ, Guillamondegui OM. Mucosal melanoma of the head and neck. Head Neck. 1991;13:22-27.
16. Guzzo M, Grandi C, Licitra L, et al. Mucosal malignant melanoma of head and neck: forty-eight cases treated at Istituto Nazionale Tumori of Milan. Eur J Surg Oncol. 1993;19:316-319.
17. Patel SG, Prasad ML, Esrig M, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck. 2002;24:247-257.
18. Gilligan D, Slevin NJ. Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses. Br J Radiol. 1991;64:1147-1150.
19. Yu NW, Eisen T, Nicolson M, et al. Mucosal malignant melanoma of the head and neck: the Marsden experience over half a century. Clin Oncol. 2003;15:199-204.
20. Owens JM, Roberts DB, Myers JN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg. 2003;129:864-868.
21. Harwood AR, Cummings BJ. Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys. 1982;8:1121-1126.
22. Shibuya H, Takeda M, Matsumoto S, et al. The efficacy of radiation therapy for a malignant melanoma in the mucosa of the upper jaw: an analytic study. Int J Radiat Oncol Biol Phys. 1993;25:35-39.
23. Wada H, Nemoto K, Ogawa Y, et al. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in northern Japan. Int J Radiat Oncol Biol Phys. 2004;59:495-500.
24. Monroe AT, Bhandare N, Morris CG, et al. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys. 2005;61:856-864.
25. Bhandare N, Monroe AT, Morris CG, et al. Does altered fractionation influence risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys. 2005. In press.